Sean Scanlan
Vermogen: 694 630 $ op 31-05-2026
Vermogen: 694 630 $ op 31-05-2026
Sean F.
Scanlan is Chief Innovation Officer at Treace Medical Concepts, Inc. since 2023.
Formerly, Dr. Scanlan was Principal at Smith & Nephew plc from 2011 to 2014.
Education includes undergraduate studies at the University of Florida and graduate and doctorate degrees from Stanford University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-03-2026 | 200.760 ( 0,31% ) | 694 630 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. | Corporate Officer/Principal | 01-01-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SMITH & NEPHEW PLC | Corporate Officer/Principal | 01-04-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Smith & Nephew plc
Smith & Nephew plc Medical SpecialtiesHealth Technology Develops, manufactures and markets medical technology devices | Health Technology |
Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic medical devices | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau